BioCentury | Mar 10, 2008
Clinical News

Chronocort: Phase II data

...causes of adrenal insufficiency in Europe. Biofusion's Diurnal Ltd. subsidiary has partnered Chronocort with Phoqus. Phoqus Pharmaceuticals plc...
BioCentury | Sep 3, 2007
Clinical News

Chronocort: Phase II started

...followed by Chronocort for about a month. BFN's Diurnal Ltd. subsidiary partnered Chronocort with PQS. Phoqus Group...
BioCentury | Aug 6, 2007
Clinical News

Chronocort: Phase III start

...006) in about 250 patients to evaluate corticosteroids plus either Chronocort or standard of care. Phoqus Group...
BioCentury | Aug 6, 2007
Clinical News

Chronocort: Phase II start

...to evaluate corticosteroids plus either Chronocort or standard of care. NIH will sponsor the trial. Phoqus Group...
BioCentury | Aug 6, 2007
Clinical News

Chronocort: Phase III start

...trial (Study 005) in about 60 to evaluate corticosteroids plus either Chronocort or standard treatment. Phoqus Group...
BioCentury | Jun 4, 2007
Clinical News

Chronocort regulatory update

...in the EU for congenital adrenal hyperplasia. BFN's Diurnal Ltd. subsidiary partnered Chronocort with PQS. Phoqus Group...
BioCentury | Jan 22, 2007
Company News

Phoqus Group plc management update

Phoqus Group plc (LSE:PQS), Kent, U.K. Business: Drug delivery Resigned: Andy Jones as CEO and a director; CFO Peter Johnson will become interim CEO WIR Staff...
Items per page:
1 - 7 of 7
BioCentury | Mar 10, 2008
Clinical News

Chronocort: Phase II data

...causes of adrenal insufficiency in Europe. Biofusion's Diurnal Ltd. subsidiary has partnered Chronocort with Phoqus. Phoqus Pharmaceuticals plc...
BioCentury | Sep 3, 2007
Clinical News

Chronocort: Phase II started

...followed by Chronocort for about a month. BFN's Diurnal Ltd. subsidiary partnered Chronocort with PQS. Phoqus Group...
BioCentury | Aug 6, 2007
Clinical News

Chronocort: Phase III start

...006) in about 250 patients to evaluate corticosteroids plus either Chronocort or standard of care. Phoqus Group...
BioCentury | Aug 6, 2007
Clinical News

Chronocort: Phase II start

...to evaluate corticosteroids plus either Chronocort or standard of care. NIH will sponsor the trial. Phoqus Group...
BioCentury | Aug 6, 2007
Clinical News

Chronocort: Phase III start

...trial (Study 005) in about 60 to evaluate corticosteroids plus either Chronocort or standard treatment. Phoqus Group...
BioCentury | Jun 4, 2007
Clinical News

Chronocort regulatory update

...in the EU for congenital adrenal hyperplasia. BFN's Diurnal Ltd. subsidiary partnered Chronocort with PQS. Phoqus Group...
BioCentury | Jan 22, 2007
Company News

Phoqus Group plc management update

Phoqus Group plc (LSE:PQS), Kent, U.K. Business: Drug delivery Resigned: Andy Jones as CEO and a director; CFO Peter Johnson will become interim CEO WIR Staff...
Items per page:
1 - 7 of 7